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Exo1 is a nuclease involved in mismatch repair, DSB
repair, stalled replication fork processing and in the DNA
damage response triggered by dysfunctional telomeres. In
budding yeast and mice, Exo1 creates single-stranded DNA
(ssDNA) at uncapped telomeres. This ssDNA accumulation
activates the checkpoint response resulting in cell cycle
arrest. Here, we demonstrate that Exo1 is phosphorylated
when telomeres are uncapped in cdc13-1 and yku70D yeast
cells, and in response to the induction of DNA damage.
After telomere uncapping, Exo1 phosphorylation depends
on components of the checkpoint machinery such as
Rad24, Rad17, Rad9, Rad53 and Mec1, but is largely
independent of Chk1, Tel1 and Dun1. Serines S372, S567,
S587 and S692 of Exo1 were identiﬁed as targets for
phosphorylation. Furthermore, mutation of these Exo1
residues altered the DNA damage response to uncapped
telomeres and camptothecin treatment, in a manner that
suggests Exo1 phosphorylation inhibits its activity. We
propose that Rad53-dependent Exo1 phosphorylation is
involved in a negative feedback loop to limit ssDNA
accumulation and DNA damage checkpoint activation.
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Introduction
The DNA damage response is an evolutionarily conserved
mechanism dedicated to cellular defence against genomic
insults (Elledge, 1996; Nyberg et al, 2002; Rouse and
Jackson, 2002). In yeast and mammals, different types
of damage, for example double-stranded breaks (DSBs) or
replication stalling, induce a DNA damage response that
triggers cell cycle arrest and expression of genes required
for DNA repair (Kolodner et al, 2002).
Primary DNA lesions are often processed by nucleases that
generate single-stranded DNA (ssDNA). Thus, ssDNA is a
common intermediate in DSB repair, nucleotide excision
repair, recombination repair and at collapsed replication
forks and is believed to have a key function in the DNA
damage response (Lydall and Weinert, 1995; Lee et al, 1998;
Pang et al, 2003). For example, upon DSB formation, the MRX
complex (the Mre11–Rad50–Xrs2 complex in yeast, or the
Mre11–Rad50–Nbs1 complex in humans) is thought to colla-
borate with the exonuclease Exo1 in the generation of 30-
ended ssDNA tracts at DSB ends, as a ﬁrst step to initiate the
repair process through homologous recombination (Ivanov
et al, 1994; Lee et al, 1998; Tsubouchi and Ogawa, 2000;
Lewis et al, 2002; Llorente and Symington, 2004; Schaetzlein
et al, 2007). ssDNA is coated with replication protein A (RPA)
(Wang and Haber, 2004). RPA-covered DNA recruits the
phosphatidylinositol 3-kinase-like protein kinase (PIKK)
Mec1 (ATR in human cells) to a region near the DSB end
(Zou and Elledge, 2003; Dubrana et al, 2007). A second set of
proteins is required with Mec1 to initiate the DNA damage
checkpoint and consists of a clamp (the Rad17–Mec3–Ddc1
complex) and a clamp loader (Rad24–RFC) (Majka et al,
2006). Mec1, in collaboration with the clamp and the clamp
loader, activates the downstream kinases Rad53 and Chk1
with the assistance of the checkpoint mediator Rad9
(Sanchez et al, 1996; Sun et al, 1996; Sweeney et al, 2005).
Activated Rad53 becomes hyperphosphorylated and is critical
for halting cell cycle progression and for DNA repair in part
through phosphorylation of downstream target kinase Dun1
(Lee et al, 2003; Chen et al, 2007).
Chromosome ends have to be distinguished from DSBs
that are potent activators of DNA damage checkpoint. For this
purpose, the telomere exerts an effect as a protective cap at
the ends of linear eukaryotic chromosomes. Telomeres ensure
genomic stability by protecting against end degradation,
recombination and fusion (Blackburn, 2001; de Lange,
2005). In budding yeast, telomeric DNA is primarily made
of a double-stranded DNA region of tandem TG1–3 repeats,
known as the G strand, which extends beyond the duplex
region, creating a short single-stranded 30 overhang
(Blackburn et al, 1989). This 30 overhang is bound by a
speciﬁc ssDNA-binding protein, Cdc13 (homologue of
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2400mammalian Pot1), which protects telomeric ends and is also
involved in recruiting telomerase complex (Nugent et al,
1996; Hockemeyer et al, 2005).
Dysfunctional telomeres (i.e. shortened or uncapped) are
at the interface between ageing and cancer (Djojosubroto
et al, 2003). Dysfunctional telomeres trigger a DNA damage
response resulting in senescence or apoptosis in mammalian
cells and are thought to exert an effect in this way as a
tumour suppressor mechanism (Campisi et al, 2001; Cosme-
Blanco et al, 2007). In budding yeast, shortened telomeres
also activate a DNA damage response, similar to the one
triggered by DSBs (Ijpma and Greider, 2003; Enomoto et al,
2004). Telomere uncapping induced in Cdc13-defective cells
(cdc13-1 mutants) leads to long tracts of single-stranded
30 DNA at and near telomere ends (Garvik et al, 1995). The
nuclease, Exo1, is involved in the generation of ssDNA and
contributes to the activation of the DNA damage checkpoint
in cdc13-1 mutants (Maringele and Lydall, 2002; Zubko et al,
2004). In addition, Exo1 has functions at other kinds of
budding yeast telomere capping defects (Maringele and
Lydall, 2002, 2004; Bertuch and Lundblad, 2004; Tsolou
and Lydall, 2007; Vega et al, 2007).
The parallel between budding yeast and mammalian cell
responses to uncapped telomeres is strong, and was recently
strengthened when a role for Exo1 at uncapped telomeres in
mice was demonstrated. Exo1 was shown to participate in the
formation of ssDNA, RPA recruitment and ATR activation in
response to telomere dysfunction in mice (Schaetzlein et al,
2007). Furthermore, in this mouse model system, mice lack-
ing Exo1 lived signiﬁcantly longer than control mice expres-
sing Exo1. This strongly suggests that regulation of Exo1
activity has the potential to affect mammalian cell responses
to uncapped telomeres and mammalian lifespan.
How Exo1 activity is regulated is largely unknown. Two
recent papers reported that human Exo1 was phosphorylated
by ATR and degraded after treatment of cells by the S-phase
inhibitor hydroxyurea (El-Shemerly et al, 2005, 2008). In
addition, our previous work in budding yeast suggested the
importance of part of the checkpoint kinase cascade, namely
Mec1, Rad9 and Rad53, in inhibiting Exo1 at uncapped
telomeres (Figure 1) (Jia et al, 2004; Zubko et al, 2004).
Here, we examine Exo1 post-translational modiﬁcation
triggered by telomere uncapping and DNA damage in bud-
ding yeast. We show that Exo1 is phosphorylated in a
checkpoint-dependent manner when telomeres are unpro-
tected. Phosphorylation is dependent on components of the
clamp (Rad17), the clamp loader (Rad24), the mediator Rad9
and the downstream kinase Rad53 and is largely dependent
on Mec1. We also show that Exo1 is phosphorylated by
induction of DNA damage. Mutation of the residues in Exo1
that are phosphorylated suggests that Exo1 is inhibited by
phosphorylation in vivo and that this phosphorylation has an
important function in modulating the cellular response to
DNA damage and uncapped telomeres.
Results
Exo1 is phosphorylated when telomeres are uncapped
Post-translational modiﬁcations (acetylation, phosphoryla-
tion, ubiquitination, glycosylation and so on) have a crucial
function in a myriad of cellular processes by affecting the
conformation, activity or stability of modiﬁed proteins (Mann
and Jensen, 2003). In particular, the DNA damage response
involves a protein phosphorylation cascade propagated
through protein kinases, most importantly Mec1, Rad53 and
Chk1 in budding yeast (Longhese et al, 1998).
To determine whether the nuclease Exo1 is modiﬁed when
telomeres are uncapped, we examined the electrophoretic
mobility of Exo1 by western blot. For this purpose, a
C-terminal Myc epitope was inserted at the EXO1 chromosomal
locus in a cdc13-1 strain and the functionality of this modiﬁed
allele was addressed by spot tests (Figure 2A). At the re-
strictive temperatures of 26 and 271C, the growth of cdc13-1
EXO1-mycHHIS3 strains was most similar to that of cdc13-1
EXO1 strains but clearly much less than cdc13-1 exo1D
strains. This demonstrates that Exo1-Myc is functional in
the context of telomere capping defects.
Telomere uncapping was induced in a cdc13-1 EXO1-
mycHHIS3 strain by growth at 361C and the mobility of
Exo1 was measured by western blot. At different times,
samples were collected and subjected to immunoblotting.
As shown in Figure 2B, optimized conditions allowed us to
detect a subtle but reproducible slower migrating form of
Exo1 after 2, 4 and 6h at 361C. Rad53, the budding yeast
Chk2 kinase, which is phosphorylated and activated as part
of the budding yeast DNA damage response, was phosphory-
lated in this assay with similar kinetics. As a control, we
conﬁrmed that this modiﬁed form of Exo1 was not due to
heat shock as it was not observed after culture of a CDC13
strain expressing Exo1-Myc at 361C for 6h (data not shown).
We conclude that Exo1 is modiﬁed after telomere uncapping
and this modiﬁcation is associated with a mobility shift
detectable by western blot.
To determine whether the modiﬁed form of Exo1 observed
after telomere uncapping is due to phosphorylation, we next
17 3
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Figure 1 Inhibition of ssDNA formation at uncapped telomeres.
A model based on that in Jia et al (2004) showing the function of
DNA damage checkpoint proteins in signalling cell cycle arrest and
inhibiting nuclease activities in response to cdc13-1-induced telo-
mere uncapping. (17,3,1) represents the Rad17, Mec3 and Ddc1
hetero-trimeric PCNA-type ring. (2,3,4,5) represents the four small
RFC subunits of the Rad24 complex. ExoX is an unidentiﬁed
exonuclease, regulated by the checkpoint sliding clamp. Other
proteins are as indicated.
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For this experiment, we used a cdc13-1 yeast strain deleted for
the protease PEP4 to avoid degradation of Exo1, observed in
vitro when proteins were extracted in non-denaturating con-
ditions after culture at 361C for more than 3h (data not
shown). Native protein extracts from a cdc13-1 pep4D
EXO1-mycHHIS3 strain incubated at 23 or 361C were treated
with lambda phosphatase. We found that phosphatase treat-
ment returned the modiﬁed form of Exo1 to its faster migrat-
ing original form, indicating that Exo1 is indeed
phosphorylated (Figure 2C). The phosphatase treatment
also reduced the mobility shift of Rad53. These ﬁndings
indicate that Exo1 is phosphorylated when telomere uncap-
ping is induced in a Cdc13-defective strain.
Exo1 phosphorylation is dependent on components
of the checkpoint machinery
Cells respond to DNA damage and uncapped telomeres by the
activation of checkpoint kinase cascades. Therefore, we
decided to investigate the dependency of Exo1 phosphorylation
on checkpoint genes. For this purpose, cdc13-1 yeast strains
expressing Exo1-Myc and deleted for RAD24, RAD17, RAD9,
RAD53, MEC1, TEL1, DUN1 or CHK1 were created. The lack of
viability of mec1D and rad53D cells was rescued by deleting the
SML1 gene, which causes an increase in dNTP synthetic
capacity (Zhao et al, 1998). For each genetic background,
Exo1 phosphorylation was assessed, in duplicate strains, by
western blot. In parallel, we examined Rad53 phosphorylation
i nt h es a m ee x t r a c t s .A ss h o w ni nF i g u r e3 A ,RAD9, RAD17,
RAD24 and RAD53 were all required for Exo1 phosphorylation
upon telomere uncapping. Thus, Exo1 phosphorylation is
dependent on components of the clamp loader (Rad24), the
clamp (Rad17), the mediator Rad9 and the effector kinase
Rad53. In addition, deletion of MEC1 largely reduces Exo1
phosphorylation, and mec1D tel1D double mutants show no
phosphorylation (Figure 3B). Finally, Figure 3C shows that
deletions of TEL1, CHK1 or DUN1 do not strongly affect Exo1
phosphorylation after telomere uncapping.
Interestingly, there is a strong correlation between Rad53
and Exo1 phosphorylation in all experiments (i.e. signiﬁcant
Exo1 phosphorylation is detected when Rad53 is phosphory-
lated at high levels and vice versa (Figures 3A and C)). This
correlation suggests that the kinase responsible for Exo1
phosphorylation is either Rad53 or a kinase downstream of
Rad53 (other than Dun1; Figure 3C). To test this hypothesis,
we examined Exo1 phosphorylation in a cell that contained
the rad53K227A (kinase dead) allele and cdc13-1 mutant at
restrictive temperature (Figure 3D). We observed that Exo1
was not phosphorylated in a strain containing the
rad53K227A allele, suggesting that Rad53, or a kinase down-
stream of Rad53, is responsible for phosphorylating Exo1
after telomere uncapping. However, we were not able to
detect a direct interaction with Exo1 and Rad53 or
Rad53KD by immunoprecipitation (data not shown).
In summary, Exo1 is phosphorylated in response to telo-
mere uncapping and this phosphorylation relies on the DNA
damage checkpoint proteins Rad24, Rad17, Rad9, Rad53 and
Mec1.
Exo1 phosphorylation is activated by a variety
of genomic insults
To determine whether Exo1 phosphorylation was speciﬁc to
deprotection of the 30 overhang in the cdc13-1 system, other
kinds of genomic stresses were induced in CDC13 cells. First,
telomeres were uncapped in a mutant deleted for YKU70. The
conserved Ku70/Ku80 heterodimer is involved in telomere
23 36 36 36 23
Exo1-Myc
Rad53
Tubulin
Temperature  (°C) Time at 36°C (h)
Time at 36°C (h)
23°C2 5 °C2 6 °C2 7 °C
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Rad53
Tubulin
Temperature (°C)
640
1108
1296
1529
1530
λ Phosphatase −−++
0
23 36 36 23
4
0246 0
40
cdc13-1 EXO1-myc::HIS3
cdc13-1 EXO1-myc::HIS3
cdc13-1 exo1Δ
cdc13-1 EXO1
WT
Figure 2 Exo1-Myc is phosphorylated when telomeres are uncapped. (A) Six-fold serial dilutions of the indicated strains were spotted onto
YPD plates and grown for 2 days at the indicated temperatures before being photographed. (B)Acdc13-1 EXO1-mycHHIS3 (DLY1529) strain,
exponentially growing at 231C, was grown for a further 6h at 231C or transferred at 361C for 2, 4 or 6h to induce telomere uncapping. Total
protein lysates were prepared by TCA extraction, separated on 7.5% SDS–PAGE and blotted on nitrocellulose membrane. Exo1-Myc, Rad53 and
tubulin were detected by western blot. (C) Native protein extracts from culture of a cdc13-1 EXO1-mycHHIS3 pep4D strain (DLY3259) grown at
23 or 361C for 4h were incubated with lambda phosphatase (þl phosphatase). Exo1-Myc, Rad53 and tubulin were detected by western blot.
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joining DNA repair process (Boulton and Jackson, 1996;
Jeggo, 1998; Hsu et al, 1999; Fisher and Zakian, 2005). At
high temperatures, yeast strains defective in Ku uncap
their telomeres, induce Exo1-dependent ssDNA formation,
and activate cell cycle arrest (Maringele and Lydall, 2002).
Importantly, Exo1 phosphorylation is detected when yku70D
mutant cells expressing Exo1-Myc are grown at 371Cf o r6 h
(Figure 4A). We conclude that Exo1 is phosphorylated in
response to different types of telomere capping defects in
budding yeast.
Exo1 is involved in mismatch repair (Fiorentini et al, 1997;
Tran et al, 2004), DSB repair (Tsubouchi and Ogawa, 2000;
Llorente and Symington, 2004) and at stalled replication forks
(Cotta-Ramusino et al, 2005; Bermejo et al, 2007). Therefore,
we tested whether Exo1 was phosphorylated after genomic
insults other than telomere uncapping. Figure 4B indicates
that Exo1 phosphorylation is observed after treatment with
the DSB-inducing agent bleomycin. To study defects in DNA
replication, we examined yeast cells defective in DNA ligase
Cdc9 (cdc9-1) (Johnston and Nasmyth, 1978). When grown at
the restrictive temperature of 361C, DNA replication is defec-
tive in cdc9-1 mutants and Exo1 phosphorylation is detected
(Figure 4B). Importantly, Exo1 phosphorylation was not
detected when cells were treated with nocodazole or alpha
factor, showing that cell cycle arrest in G2/M or G1 does not
induce Exo1 phosphorylation (Supplementary Figure 1).
Taken together, our data clearly show that Exo1 phosphory-
lation is a common response to DNA damage caused by a
variety of genomic insults.
cdc13-1 mec1Δ
sml1Δ
Exo1-Myc
Rad53
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Rad53
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Anti-Rad53
cdc13-1 mec1Δ 
sml1Δ tel1 Δ     
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cdc13-1 cdc13-1 rad24Δ cdc13-1 cdc13-1 rad17Δ cdc13-1 cdc13-1 rad9Δ cdc13-1
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Figure 3 The phosphorylation of Exo1 is checkpoint dependent. All strains carried EXO1-mycHHIS3. For each experiment, two different strains
with the same genotype, indicated as A and B were examined. (A) cdc13-1 (DLY1529) and cdc13-1 rad24D (DLY2974 and DLY2975), cdc13-1
rad17D (DLY3844 and DLY3845), cdc13-1 rad9D (DLY3009 and DLY3010), cdc13-1 rad53D sml1D (DLY3073 and DLY3074), strains exponentially
growing at 231C, were grown for a further 6h at 23 or 361C. Western blots of TCA protein extracts were ﬁrst probed with anti-Myc antibodies to
detect Exo1-Myc. Membranes were stripped and reprobed with anti-Rad53 antibodies. (B) As in (A) but with cdc13-1 mec1D sml1D strains
(DLY4146 and DLY3261) and cdc13-1 mec1D sml1D tel1D strains (DLY4115). (C) As in (A) but with cdc13-1 tel1D (DLY3002 and DLY3003),
cdc13-1 chk1D (DLY3011 and DLY3012), cdc13-1 dun1D strains (DLY3077 and DLY3078). (D) As in (A) but with cdc13-1 Rad53KD strain
(DLY3568 and DLY3569).
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to uncapped telomeres
To understand why and how Exo1 is phosphorylated in
response to telomere uncapping, it was important to deter-
mine the identity of the phosphorylated sites. For this pur-
pose, Exo1 was puriﬁed using a TAP epitope fused in frame at
the C terminus (Rigaut et al, 1999). A cdc13-1 EXO1-
tapHURA3 strain was created and the functionality of Exo1-
Tap was assessed by spot tests. As shown in Figure 5A, cdc13-1
EXO1-tapHURA3 and cdc13-1 EXO1 strains grew similarly
showing that Exo1-Tap is functional. To avoid degradation of
Exo1 when incubating cells for more than 3h at 361C, we also
used a strain deleted for PEP4, coding for the vacuolar protease
Pep4 (Figure 5A). cdc13-1 EXO1-tapHURA3 strains were grown
at 231Co ra t3 6 1C for 3h and a ‘quick’ TAP puriﬁcation was
performed to preserve as many post-translational modiﬁcations
as possible (Materials and methods). Figure 5B lane 1 shows
TAP puriﬁcation from cells grown at 231C, lane 3 shows
samples grown at 361C and lane 5 is a control puriﬁcation
from a non-epitope-tagged strain. Lanes 1 and 3 show a single
extra band, marked with a star, not detected in the control lane
(lane 5). This band was identiﬁed as Exo1-Tap by western blot
(data not shown). Puriﬁcation of Exo1 did not reveal any other
extra band(s), suggesting that we were not able to identify
any protein partners of Exo1 either in exponentially dividing
cells or in cells arrested at the checkpoint due to telomere
uncapping.
The Exo1-Tap bands from lanes 1 and 3 and from a cdc13-1
EXO1-tapHURA3 pep4D strain grown for 4h at 361C (not
shown) were excised and digested with trypsin. The digests
were analysed by LC-MS with precursor 79 scanning as
described previously (Williamson et al, 2006). The tryptic
digests were also analysed on an LTQ-orbitrap mass spectro-
meter coupled to a Dionex 3000 nano LC system (Materials
and methods). As shown in Figure 5C, a dramatic increase is
seen in the peak intensities for phosphorylated Exo1, puriﬁed
when telomere uncapping was induced (grey line, compared
with red line, 231C control). We mapped four distinct major
phosphorylation sites induced in Exo1 after telomere uncap-
ping and the same residues in Exo1 were identiﬁed after
culture of a cdc13-1 EXO1-tapHURA3 pep4D strain for 4h at
361C. We conclude four phosphorylated serines, S372, S567,
S587 and S692, are major targets of the DNA damage re-
sponse triggered by uncapped telomeres in a Cdc13-defective
strain. Consistent with our results, others identiﬁed S372, but
no other residues in Exo1, in a proteomic screen for budding
yeast DNA damage checkpoint kinase targets after treatment
of cells with the alkylating agent MMS (Smolka et al, 2007).
Exo1 phosphorylation mutant alleles exhibit different
responses to telomere uncapping and DNA damage
To examine the effect of Exo1 phosphorylation on the DNA
damage response, we mutated Exo1 phosphorylation sites.
The EXO1-tap construct and 900bp upstream was ampliﬁed
from yeast by PCR and subcloned in the single-copy vector
pRS413 to create pRS413-Exo1-Tap. We checked by western
blot that Exo1 expression level by the pRS413-Exo1-Tap in
cdc13-1 exo1D was similar to the expression level generated
by the integrated EXO1-tap allele (Supplementary Figure 2).
The four serine residues S372, S567, S587 and S692 were
converted into alanine (Exo1-4SHA-Tap) or glutamic acid
(Exo1-4SHE-Tap). Conversion of serine to alanine blocks
the phosphorylation on these residues, whereas the negative
charge of the glutamic acid mimics the negative charge
carried by a phosphorylated serine residue.
The growth of cdc13-1 exo1D strains expressing WT Exo1-
Tap, Exo1-4SHA-Tap or Exo1-4SHE-Tap on centromeric plas-
mids was analysed, in duplicate, by spot tests at a range of
temperatures (Figure 6A). cdc13-1 exo1D strains expressing
Exo1-Tap or mutants grew less well than cdc13-1 exo1D
carrying the empty vector pRS413 at 281C (data not
shown). We conclude that Exo1-Tap, Exo1-4SHA-Tap and
Exo1-4SHE-Tap are all functional. However, at 271C and
particularly noticeable at 26.51C, we detected differences in
growth between cells expressing Exo1-Tap, Exo1-4SHA-Tap
or Exo1-4SHE-Tap. At 26.51C, cdc13-1 strains expressing
Exo1-4SHA-Tap grow poorly compared with cdc13-1 expres-
sing Exo1-Tap and Exo1-4SHE-Tap. We can conclude from
this, and our observation that overexpression of Exo1 is
detrimental to the growth of the cdc13-1 mutants
(Supplementary Figures 3 and 4), that Exo1-4SHA is more
active than either Exo1 or Exo1-4SHE. In addition, we also
found that cdc13-1 strain expressing Exo1-4SHE-Tap grew
better than cdc13-1 expressing Exo1-4SHA-Tap or Exo1-Tap
at 26 and 26.51C. The effects of Exo1 mutations are subtle but
Exo1-Myc
Rad53
Bleo
T (°C)
Exo1-Myc
Rad53
23 36
23 36 23 37 23 23 37
23 36 36 23 23 23 23 23 23 23
– – – – – – – – + – ++ –
cdc13-1 CDC13  cdc9-1 cdc13-1 CDC13
AB
cdc13-1 CDC13  yku70Δ
Figure 4 Exo1 phosphorylation is induced by a range of genomic
insults. All strains carried EXO1-mycHHIS3.( A)Acdc13-1
(DLY1529) and CDC13 yku70D strain (DLY3405 and DLY3406),
exponentially growing at 231C, were grown for a further 6h at
231C or transferred at higher temperature (36 and 371C) to induce
telomere uncapping. Western blots were performed as in Figure 3
and two different strains with the same genotype, indicated as
A and B were examined. (B) cdc13-1 (DLY1529), exponentially
growing at 231C, was transferred to 361C for 6h. Left panel: cell
cultures of CDC13 cdc9-1 (DLY3262), exponentially growing at 231C,
were transferred to 361C for 6h. Right panel: cell cultures of CDC13
(DLY3079) were grown at 231C in YPD and transferred into YPD
with bleomycin (50mg/ml), samples were taken at 2h (þ) and 4h
(þþ). Western blots of TCA protein extracts were ﬁrst probed with
anti-Myc antibodies to detect Exo1-Myc. Membranes were stripped
and reprobed with anti-Rad53 antibodies.
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phosphorylation reduces the ability of Exo1 to respond to
uncapped telomeres.
To better test the effects of serine to alanine or serine to
glutamic acid mutations in Exo1, we integrated the alleles
into the normal EXO1 chromosomal locus. First, we showed
that strains carrying a truncated Exo1 (exo1D 1091–2109),
which was used to generate the mutated EXO1 strains,
showed a loss of function similar to exo1D strains
(Figure 6B). We found that Exo1-4SHE was less functional
than Exo1 when expressed from the normal locus because
cdc13-1 exo1-4SHE mutants formed larger colonies than
cdc13-1 EXO1 strains at 26 and 26.51C. However, we were
unable to observe an effect of the exo1-4SHA mutations, at
the EXO1 locus, in cdc13-1 mutants.
To test whether the phosphorylation of Exo1 affected
responses to other types of DNA damage, we treated cells
with the topoisomerase I poison camptothecin. This drug is
believed to exert its toxicity through the generation of repli-
cation-associated DSBs (Pommier et al, 2003). Under this
condition, DNA end resection by Exo1 and the ensuing repair
is expected to be beneﬁcial to cell growth and survival. This
view is supported by the ﬁndings that strains carrying EXO1
truncation or deletion show sensitivity to camptothecin
(Figure 6C and data not shown). After camptothecin treat-
ment, we found that cells expressing Exo1-4SHA from the
chromosomal locus were slightly more resistant to treatment
compared with EXO1 strains, whereas the strains expressing
Exo1-4SHE were more sensitive than EXO1 strains
(Figure 6C). Although subtle, these results obtained from
plasmid and integrated alleles strongly suggest that Exo1
phosphorylation inhibits the activity of Exo1 in response to
telomere uncapping and camptothecin treatment.
One explanation for the comparatively subtle effects of the
Exo1-4SHA and Exo1-4SHE mutations might be that other
serine (threonine or tyrosine) residues were phosphorylated
when the primary kinase targets had been mutated.
Consistent with this idea, there are 61 serines, 36 threonines
and 21 tyrosines in Exo1. To test this hypothesis, we epitope-
tagged exo1-4SHA and exo1-4SHE alleles at the EXO1 locus
with the Myc epitope. In response to telomere uncapping,
there was a clear increase in mobility of both Exo1-4SHA-Myc
and Exo1-4SHE-Myc (Figure 6D). We conclude that in the
absence of the primary phosphorylation targets Exo1 is
modiﬁed at additional positions. Taken together, all our
data suggest that Exo1 phosphorylation is regulated by and
regulates the DNA damage response upon telomere uncap-
ping and after treatment with camptothecin.
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Figure 5 Identiﬁcation of Exo1-phosphorylated sites upon telomere uncapping. (A) Spot test shows six-fold serial dilutions of the indicated
strains on YPD grown for 3 days at the indicated temperatures. (B) cdc13-1 EXO1-tapHURA3 strain (DLY2998) (3l), growing exponentially at
231C, was further incubated at 231C or transferred to 361C for 3h. Low stringency puriﬁcation of Exo1Tap was performed (lanes 1 and 3). A
band identiﬁed as Exo1-Tap from lanes 1 and 3 is indicated by a star. Lanes 2 and 4 show molecular weight (MW) markers and sizes are
indicated on the right. Lane 5 is a control and shows proteins extracted from a culture of cdc13-1 EXO1 strain (DLY1108) grown for 3h at 361C.
(C) Exo1 bands, similar to those shown in (B), at 231C (lane 1, *) and at 361C (lane 3, *) were analysed by mass spectrometry. The extracted ion
chromatograms for the phosphopeptide ions detected by precursor ion scanning are showed for the tryptic digests of Exo1 grown at 231C (red
trace) or cultured for 3h at 361C (grey trace). The masses of the detected peptides are average masses (m/z) for the doubly negatively charged
peptide ions ([M-2H]2 ). Identity of phosphorylated serine residues are shown as red and underlined in Exo1 sequence.
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The DNA damage response is a powerful intracellular net-
work that has the potential to repair damage, induce cell cycle
arrest and in some cell types, induce apoptosis or senescence.
To ensure that the DNA damage response works to the beneﬁt
of its host cell and organism, it is essential that responses to
DNA damage are appropriately measured and properly regu-
lated. Here, we show that Exo1, an evolutionarily conserved
double strand-speciﬁc 50 to 30 exonuclease, involved in mis-
match repair, DSB repair, meiosis and in responding to stalled
replication forks and uncapped telomeres, is targeted and
phosphorylated by the DNA damage checkpoint pathway.
Previous experiments have shown that Exo1 is critical for
generating ssDNA at three classes of uncapped telomeres in
budding yeast (cdc13-1, yku70D and telomerase knockout,
tlc1D, cells; Maringele and Lydall, 2002, 2004; Bertuch and
Lundblad, 2004; Zubko et al, 2004). Exo1-dependent ssDNA
appears to be a stimulus for the DNA damage checkpoint that
results in cell cycle arrest in all three cases. In a similar way in
mice, Exo1-dependent ssDNA formation ampliﬁes the DNA
damage signal at dysfunctional telomeres (Schaetzlein et al,
2007).
Here, we show that a subset of DNA damage checkpoint
proteins, Mec1, Rad17, Rad24, Rad9 and Rad53, has a crucial
function in Exo1 phosphorylation and consequently modu-
lates the accumulation of ssDNA at uncapped telomeres (this
paper and Jia et al, 2004). Other checkpoint proteins, Dun1,
Chk1 and Tel1 do not have an important function in this
process.
We found that Exo1 was strongly phosphorylated on resi-
dues S372, S567, S587 and S692 in the C terminus. The
phenotype of mutating these residues to alanines, to prevent
phosphorylation, or glutamic acids, to mimic phosphorylation,
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Figure 6 Exo1 phosphorylation mutant alleles exhibit different responses to telomere uncapping and DNA damage. (A) Spot test shows six-
fold serial dilutions of cdc13-1 exo1D (DLY1296) strains carrying pRS413-Exo1-Tap, pRS413, pRS413-Exo1-4SHA-Tap or pRS413-Exo1-4SHE-Tap.
Two independent transformant clones are shown (Cl1 and Cl2) and are representative of 10 clones tested in each case. (B) Spot test shows six-
fold serial dilutions of cdc13-1 exo1D1091–2109HURA3 (DLY4008), cdc13-1 EXO1 (DLY4067), cdc13-1 exo1-4SHA (DLY4068) and cdc13-1 exo1-
4SHE strains (DLY4069 and DLY4070). The plates were incubated at the temperature indicated for 2 days before the photographs were taken.
(C) Spot test shows six-fold serial dilutions of cdc13-1 exo1D1091–2109HURA3 (DLY4008), cdc13-1 EXO1 (DLY4067), cdc13-1 exo1-4SHA
(DLY4068) and cdc13-1 exo1-4SHE strains (DLY4069 and DLY4070). The plates were incubated for 4 days at 201C before the photographs were
taken. (D) cdc13-1 exo1-4SHA-mycHHIS3 (DLY4138) and cdc13-1 exo1-4SHE-mycHHIS3 (DLY4096) strains, exponentially growing at 231C, were
grown for a further 6h at 231C or transferred to 361C for 2, 4 or 6h. Total protein lysates were prepared by TCA extraction, separated on 7.5%
PAGE and blotted onto nitrocellulose membrane. Exo1-Myc and tubulin were detected by western blot as in Figures 2–4.
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Exo1 in vivo. We propose that Exo1 phosphorylation limits the
accumulation of ssDNA at unprotected telomeres, and there-
fore participates in a negative feedback loop to limit DNA
damage checkpoint activation. Consistent with this conclusion,
we ﬁnd that expression of Exo1-4SHA and overexpression of
Exo1 hyperactivates the DNA damage response in cells with
uncapped telomeres (Supplementary Figures 3–5).
As Exo1 is a protein involved in many different DNA repair
pathways, we suggest that Exo1 modiﬁcation may exert an
effect to downregulate Exo1 activity after many different
kinds of damage. Such a modiﬁcation would also exert an
effect to limit the accumulation of ssDNA at damaged DNA.
Consistent with this hypothesis, we observed Exo1 phosphor-
ylation after treatment with the DSB-inducing agent, bleomy-
cin and after inactivation of DNA ligase I. We also show that
altering Exo1 phosphorylation affects sensitivity to camp-
tothecin, in a manner that again suggests inhibitory role of
phosphorylation on Exo1 activity (Figure 6C).
There are several possible mechanisms by which charge
effects caused by phosphorylation of Exo1 might inhibit its
activity. The most direct would be if phosphorylation of Exo1
inhibited the 50 to 30 exonuclease activity exhibited by Exo1.
Phosphorylation of the C terminus might induce conforma-
tional changes that affect the recruitment of Exo1 to DNA
and/or inhibit Exo1 activity. Another mechanism would be if
the phosphorylation of Exo1 affects the ability of Exo1 to
move through chromatin. As DNA damage induces chroma-
tin modiﬁcations near DNA lesions, it seems conceivable, and
indeed perhaps desirable, that chromatin structure near DNA
damage prevents access of phosphorylated Exo1. Such an
interaction would exert an effect to limit the accumulation of
ssDNA near uncapped telomeres, DSBs or other types of
lesions. Another possibility is that phosphorylation of Exo1
affects interaction of Exo1 with other proteins, for example, a
nuclease activator or inhibitor. It has been reported pre-
viously that interactions between Exo1 and the mismatch
repair proteins Mlh1 and Msh2 involve the Exo1 C terminus
(Tishkoff et al, 1997; Schmutte et al, 2001; Tran et al,2 0 0 1 ,
2002). As the four phosphorylated serine residues have been
identiﬁed at Exo1 C terminus, we can envisage that phos-
phorylation may affect the interactions between Exo1 and
Mlh1 or Msh2. Finally, two recent studies in mammalian cells
reported that Exo1 is ubiquitinated, and degraded, after DNA
is damaged in the presence of hydroxyurea (El-Shemerly
et al, 2005, 2008). In many cases, phosphorylation is an
important signal for proteins to be recognized as targets by
the proteasome–ubiquitin pathway. It seemed plausible that
ubiquitination and degradation may indeed occur for bud-
ding yeast Exo1 and contribute to its inhibition. However, we
saw no degradation of Exo1 when proteins were extracted in
denaturating conditions (TCA) after telomere uncapping. The
degradation we observed in vitro when proteins were ex-
tracted in native conditions after 4h at 361C was dependent
on the vacuolar protease PEP4.
In conclusion, regulation of Exo1 upon telomere uncap-
ping involves checkpoint-dependent phosphorylation, lead-
ing to the inhibition of Exo1. We believe that Rad53
(homologue of Chk2 in human cells) has a key function in
this process and is most likely the kinase responsible for Exo1
phosphorylation. Examples are beginning to be identiﬁed
where targets of the DNA damage response regulate DNA
damage processing. For example, the mammalian homolo-
gous recombination protein, BRCA1, is phosphorylated by
Chk2 and this seems to affect whether homologous recombi-
nation or non-homologous end joining pathways are used to
repair DSBs (Wang et al, 2006; Zhuang et al, 2006). If our
experiments in yeast can be extrapolated to mammalian cells,
we suggest that Chk2 inhibitors may affect the generation of
ssDNA as well as downstream aspects of cell cycle arrest
pathways in cells with telomere capping defects. Therefore,
Chk2 inhibitors may also, similar to Exo1 deletion does in
mice and yeast cells, improve the vitality of cells and animals
with telomere capping defects, and perhaps, have a positive
effect on mammalian ageing.
Materials and methods
Yeast strains
All the strains used in this study are in the W303 genetic
background and are RAD5
þ, unless otherwise stated in Supple-
mentary Table 1. A Myc epitope containing 13 copies was ampliﬁed
by PCR using the plasmid pFA6a-13Myc-His3MX6 as a template
(Longtine et al, 1998). The PCR product carrying the HIS3 marker
was transformed into cdc13-1 yeast strain to generate cdc13-1 EXO1-
mycHHIS3 strains expressing Exo1-Myc (DLY1529 and DLY1530).
Similarly, a Tap epitope was ampliﬁed by PCR using the plasmid
pBS1539 as a template (Puig et al, 2001). The PCR product carrying
the URA3 marker was then transformed into cdc13-1 strain to
generate the strain cdc13-1 EXO1-tapHURA3 (DLY2998). Correct
integration was checked by PCR and/or Southern blot. Standard
genetic crosses were used to obtain all the other strains from this
study.
Cell cultures
Asynchronous cells were grown in YPD or selective medium until they
reached the exponential growth rate (OD600¼0.8). Then different
treatments were applied. To induce telomere uncapping, cdc13-1 and
yku70D strains are incubated at the temperatures indicated in the
ﬁgures. For cells treated with damaging agents, bleomycin (50mg/ml;
Sigma; 203408) was added to the cells for 2 or 6h.
Cell lysis under denaturating conditions and western blot
analysis
Protein extracts were prepared by glass bead breakage in TCA,
essentially as previously described (Foiani et al, 1994). Brieﬂy, cells
were collected, washed once in water and resuspended in 10% TCA.
Cells were mechanically broken using glass beads. Protein
suspensions were pelleted, resuspended in Laemmli buffer (Bio-
Rad; 161-0737) and the pH was equilibrated using Tris 1M. Samples
were boiled for 3min, centrifuged for 10min at 3000r.p.m. and the
supernatant was retained as the protein extract. For western
blotting, proteins were separated on 7.5% SDS–PAGE (Bio-Rad;
161-1172). Gels were run for 2.5h at 30mA to maximize as much as
possible the mobility shift between phosphorylated Exo1 and the
non-phosphorylated form of Exo1. C-Myc antibody 9E10 was from
Cancer Research UK. Peroxidase–anti-peroxidase soluble complex
antibody from Sigma (P1291) was used to detect the TAP epitope.
Antibodies against Rad53 were from Dan Durocher, Toronto. Anti-
tubulin antibodies from Keith Gull, Oxford.
Cell lysis in non-denaturating conditions and
dephosphorylation assay
Native protein extraction resulted in low yields of Exo1 in cdc13-1
mutants grown at 361C for more than 3h. To improve yields, we
deleted PEP4, encoding a vacuolar protease in cdc13-1 EXO1-
mycHHIS3 pep4D strain (DLY3280). Yeast strain cdc13-1 EXO1-
mycHHIS3 pep4D was then grown for 4h at 23 or 361C and whole-
cell extracts were prepared by glass bead beating in a non-
denaturing lysis buffer LB (Hepes 20mM, NaCl 0.15M, glycerol
10%, Tween 0.1%, phenylmethylsulphonyl ﬂuoride 1mM, protease
inhibitor mixture (Roche Applied Science)). The dephosphorylation
assays were carried out by incubating 50mg of protein extracts in
lambda phosphatase buffer supplemented with 2mM MnCl2
containing 1ml of lambda phosphatase (l-PPase; New England
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stopped by adding an equal volume of 2  Laemmli buffer and
incubation at 951C for 3min.
Quick TAP puriﬁcation
cdc13-1 EXO1-tapHURA3 (DLY2998) strain (6l) was grown at 231C
in YPD medium until OD600 reached 0.8. A portion of 3l was
incubated further for 3h at 231C and 3l was incubated in parallel at
361C for 3h to induce telomere uncapping. A cdc13-1 EXO1-
tapHURA3 pep4D (DLY3280) strain was incubated for 4h at 361C.
Cells were harvested and washed twice with chilled water and once
with lysis buffer LB (Hepes 20mM, NaCl 0.15M, glycerol 10%,
Tween 0.1%). Pellets were resuspended in 20ml of LB containing
1mM phenylmethylsulphonyl ﬂuoride, one tablet antiprotease
complete (Roche Applied Science), NaF 1mM, Nab glyceropho-
sphate 0.8mM, 400ml of cocktail antiphosphatase IV (Merck;
524628) and 330ml of cocktail antiphosphatase II (Sigma; P5726)
and dripped into liquid nitrogen. Cells were disrupted by grinding in
a mechanical pestle and mortar as described previously (Caspari
et al, 2000). To purify TAP-tagged proteins, powdered cell lysates
were thawed at 41C and a volume of 10ml of lysis buffer was added
to the cell extracts. The lysates were clariﬁed by spinning at
13000r.p.m. for 10min. Proteins were immunoprecipitated by
incubation at 41C for 2h with 450ml of IgG (rabbit gamma globulin;
Invitrogen)-coupled Dynal beads (Dynabeads-M-280 Tosylacti-
vated; Invitrogen; 142-03) pre-equilibrated into lysis buffer. Beads
were recovered and washed six times with 3ml of lysis buffer.
Beads were then resuspended in 30ml of Laemmli buffer and boiled
for 10min at 751C. The supernatant was loaded in a 7.5% SDS–
PAGE (Tris-glycine, 7.5%; Bio-Rad; 161-1172). Gels were stained for
2h with Brilliant Blue G-Colloidal (Sigma; B-2025) and bands were
excised and subjected to MALDI-TOF mass spectrometry.
Proteomic analysis
Tryptic digests were separated on a 150 0.075mm Vydac C18 column
(Grace Analytical) equilibrated in 2% acetonitrile/0.1% formic acid
and the column was developed with a linear 2–40% acetonitrile
gradient in 40min at 300nl/min. The masses of potential tryptic
phosphopeptides detected by precursor ion scanning were calculated
to 10p.p.m. mass accuracy and entered into an inclusion list.
Precursors were analysed in the orbitrap set to a resolution of
60000 and tandem MS/MS was performed in the LTQ with multistage
activation (MSA) of the precursors and precursor  98/z, as described
previously (Schroeder et al, 2004). The composite MSA spectra were
searched against a local database using Mascot (Matrixscience) run
on a local server with the search criteria set to 10p.p.m. mass
accuracy for precursors allowing for one tryptic missed cleavage,
carboxyamidomethylation of cysteine, oxidation of methionine and
phosphorylation of serine, threonine or tyrosine.
Site-directed mutagenesis
The EXO1TAP fusion gene plus 900bp upstream was ampliﬁed by
PCR (forward primer 1257: ggaatcacgactcgagaattgttcatcttaatcaaggagg
and reverse primer 1258: ggatcccccgggcttcaggaattcgatatcaagcttcagg)
from the strain cdc13-1 EXO1-tapHHIS3 (DLY2998) and cloned in
pCR
s4-TOPO (Invitrogen; K4575-01). EcoRV and XhoI restriction sites
were inserted into the primers and used to subclone EXO1-tap into
plasmid pRS413. The resulting plasmid was designated pRS413-Exo1-
Tap (pDL1124) and the inserted DNA was sequenced. Using EcoRV
and XhoI restriction sites, the promoter sequence and EXO1-tap were
subcloned in pRS423 to generate pRS423-Exo1-Tap (pDL1126).
EXO1TAP gene was also ampliﬁed by PCR from the strain cdc13-1
EXO1-tapHURA3 (DLY2998) using primers carrying HindIII restriction
sites (forward primer 1259: ccttcaggtatatctataagctttcatagaattaaatttga-
tattgc and reverse primer 1260: ctgcaggaattcgatatcaagcttcaggtt-
gacttccccgc). A PCR fragment was cloned in pCR
s4-TOPO for
sequencing and subcloned in YEp181PALEH (pYep) using HindIII
restriction sites (Lowe et al, 2004). pYep-Exo1-Tap (pDL1116) allows
expression of Exo1Tap under the constitutive ADH1 promoter. The
pRS413-Exo1-Tap (pDL1124) was used as a template to produce
mutants by the QuikChange
s Multi Site-Directed Mutagenesis Kit
from Stratagene (200515). The EXO1 gene was then mutated to
generate the desired codon changes corresponding to the following
mutations S372A, S372E, S567A, S567E, S587A, S587E, S692A and
S692E. Plasmids pRS413-Exo1-4SHA-Tap (pDL1143) and pRS413-
Exo1-4SHE-Tap (pDL1145) were obtained and the sequence of
mutated EXO1 was conﬁrmed by sequencing.
Integration of point mutations into the genome
To create strains carrying exo1-4SHA and exo1-4SHE mutations, EXO1
gene was ﬁrst truncated in a strain carrying cdc13-1 mutation
(DLY1108). The EXO1 truncation cassette was ampliﬁed by PCR from
plasmid Ycplac33 using primers 1442 (aatccatatgattttcaccaacctctagc
caacagagagccctttcgtcttcaagaattagc) and 1439 (gaaaaatatacctccgatatg
aaacgtgcagtacttaactttcttgccacgactcatctcc), and the truncation cassettes
were transformed into DLY1108, creating a strain with the entire C
terminus of EXO1 removed, DLY4008 (cdc13-1 exo1D1091–
2109HURA3). The corresponding truncated section of EXO1 was then
replaced by mutated and correct (as a control) versions of EXO1.
EXO1, exo1-4SHA and exo1-4SHE fragments were ampliﬁed by PCR
from plasmids pDL1124, pDL1143 and pDL1146, respectively, using
primers 1447 (aatccatatgattttcaccaacctctagccaacagagagc) and 1448
(gaaaaatatacctccgatatgaaacgtgcagtacttaacttttatttacctttataaacaaattgggaa
agc). These fragments were then transformed into DLY4008 with a
carrier plasmid pRS425 (2m,L E U ) .L e uþ transformants were replica-
plated onto 5FOA plates to select for correct replacement transfor-
mants. These positive transformants were then conﬁrmed by spot test
and DNA sequencing.
Spot tests
Single colonies were inoculated into 2ml YPD or selective medium
( Leu or  Ura) and incubated at 231C until saturation. Cells were
then diluted to a concentration of 1.5 10
7 cells/ml in the
corresponding media. A ﬁve-fold dilution series of each of the
cultures was prepared in a 96-well plate and 3–5mlw a ss p o t t e do n t o
plates using a 48-prong replica-plating device. Plates were incubated
for 2–4 days at different temperatures before being photographed.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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